BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28081971)

  • 1. Demand- and supply-side determinants of diphtheria-pertussis-tetanus nonvaccination and dropout in rural India.
    Ghosh A; Laxminarayan R
    Vaccine; 2017 Feb; 35(7):1087-1093. PubMed ID: 28081971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2012 Apr; (4):CD005530. PubMed ID: 22513932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative tetanus antibody response of Nigerian children to diphtheria-pertussis-tetanus and pentavalent vaccines.
    Uket HO; Ekanem EE; Okpara HC; Ekrikpo UE
    Niger Postgrad Med J; 2018; 25(3):137-142. PubMed ID: 30264763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subnational inequalities in diphtheria-tetanus-pertussis immunization in 24 countries in the African Region.
    Kirkby K; Bergen N; Schlotheuber A; Sodha SV; Danovaro-Holliday MC; Hosseinpoor AR
    Bull World Health Organ; 2021 Sep; 99(9):627-639. PubMed ID: 34475600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are we progressing towards elimination of diphtheria, pertussis, tetanus from Nepal?
    Jha N; Kumar S
    Kathmandu Univ Med J (KUMJ); 2008; 6(24):520-5. PubMed ID: 19483439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps.
    Awofeso N; Rammohan A; Iqbal K
    BMC Public Health; 2013 Apr; 13():358. PubMed ID: 23594400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
    McCormack PL
    Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study.
    Gillard P; Tamura T; Kuroki H; Morikawa Y; Moerman L; Parra J; Kitamura Y; Mihara K; Okamasa A
    Hum Vaccin Immunother; 2019; 15(4):800-808. PubMed ID: 30785851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the spatial heterogeneity in different doses of vaccination coverage in India.
    Khan J; Shil A; Prakash R
    PLoS One; 2018; 13(11):e0207209. PubMed ID: 30485291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage, Opportunity, and Challenges of Expanded Program on Immunization among 12-23-Month-Old Children in Woldia Town, Northeast Ethiopia, 2018.
    Abebe AM; Wudu Kassaw M; Zemariam AB; Estifanos Shewangashaw N
    Biomed Res Int; 2019; 2019():5302307. PubMed ID: 31976321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
    Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
    Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.
    Plosker GL
    BioDrugs; 2009; 23(4):253-67. PubMed ID: 19697967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse events following diphtheria, pertussis and tetanus vaccinations and factors associated with severity].
    Freitas FR; Sato HK; Aranda CM; Arantes BA; Pacheco MA; Waldman EA
    Rev Saude Publica; 2007 Dec; 41(6):1032-41. PubMed ID: 18066473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization.
    Frampton JE; Keating GM
    BioDrugs; 2006; 20(6):371-89. PubMed ID: 17176125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.